# Study of KCC Peptide Application in the Colon

> **NCT02156557** · PHASE1 · COMPLETED · sponsor: **Danielle Kim Turgeon** · enrollment: 45 (actual)

## Conditions studied

- Colon Polyps
- Colorectal Cancer
- Inflammatory Bowel Disease (IBD)

## Interventions

- **BIOLOGICAL:** Colon KCC Heptapeptide

## Key facts

- **NCT ID:** NCT02156557
- **Lead sponsor:** Danielle Kim Turgeon
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2016-07
- **Final completion:** 2016-08
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2017-04-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02156557

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02156557, "Study of KCC Peptide Application in the Colon". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02156557. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*